Could just 1 course of radiotherapy help treat osteoarthritis pain?

Translate to Spanish or other 102 languages!

Radiation therapy or radiotherapy is an underutilized noninvasive treatment option for osteoarthritis, but data from clinical trials have been mixed. Image for illustration purposes
Radiation therapy or radiotherapy is an underutilized noninvasive treatment option for osteoarthritis, but data from clinical trials have been mixed. Image for illustration purposes
- Advertisement -

Medical News Today 

The first line of treatment for osteoarthritis includes physical therapy and oral medications but procedures such as direct injection of medications into the joint and surgery are necessary in more severe cases.

Radiation therapy or radiotherapy is an underutilized noninvasive treatment option for osteoarthritis, but data from clinical trials have been mixed.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/1-course-radiotherapy-osteoarthritis-pain?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-10-07&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -